| ŠUSTR, Filip and Miroslav SOUČEK. Rivaroxaban ve studii COMPASS (Rivaroxaban in COMPASS trial). Vnitřní lékařství. Solen, s. r. o., 2020, vol. 66, No 3, p. 197-198. ISSN 0042-773X. Available from: https://dx.doi.org/10.36290/vnl.2020.050. |
Other formats:
BibTeX
LaTeX
RIS
@article{1833559,
author = {Šustr, Filip and Souček, Miroslav},
article_number = {3},
doi = {http://dx.doi.org/10.36290/vnl.2020.050},
keywords = {COMPASS, rivaroxaban, ASA, coronary artery disease},
issn = {0042-773X},
journal = {Vnitřní lékařství},
title = {Rivaroxaban ve studii COMPASS},
volume = {66},
year = {2020}
}
TY - JOUR
ID - 1833559
AU - Šustr, Filip - Souček, Miroslav
PY - 2020
TI - Rivaroxaban ve studii COMPASS
JF - Vnitřní lékařství
VL - 66
IS - 3
SP - 197-198
EP - 197-198
PB - Solen, s. r. o.
SN - 0042773X
KW - COMPASS, rivaroxaban, ASA, coronary artery disease
ER -
ŠUSTR, Filip and Miroslav SOUČEK. Rivaroxaban ve studii COMPASS (Rivaroxaban in COMPASS trial). \textit{Vnitřní lékařství}. Solen, s. r. o., 2020, vol.~66, No~3, p.~197-198. ISSN~0042-773X. Available from: https://dx.doi.org/10.36290/vnl.2020.050.
|
